2012年8月28日
;79 (9)
文章
一个简单的分数估计骨折多发性硬化症患者的长期风险
玛洛t Bazelier,当前科技成果鉴定Tjeerd-Pieter范,伯纳德M.J. Uitdehaag,赛勒斯·库珀,休伯特通用Leufkens,据我,琼Bentzen,弗兰克•德•弗里斯
第一次出版2012年8月15日,
DOI: https://doi.org/10.1212/WNL.0b013e318266faae
玛洛t Bazelier
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
MSc
当前科技成果鉴定Tjeerd-Pieter范
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
医学博士
伯纳德M.J. Uitdehaag
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
医学博士
赛勒斯·库珀
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
妈,DM, FRCP FMedSci
休伯特通用Leufkens
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
PharmD博士
据我
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
医学博士,DrMedSc
琼Bentzen
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
硕士,博士
弗兰克•德•弗里斯
乌得勒支医药科学研究所(M.T.B.,T.-P.v.S。,H.G.M.L.,F.d.V.), Utrecht University, Utrecht, Netherlands; General Practice Research Database (T.-P.v.S.), Medicines and Healthcare Products Regulatory Agency, London, UK; MRC Lifecourse Epidemiology Unit (T.-P.v.S., C.C., F.d.V.) University of Southampton, Southampton, UK; MS Center Amsterdam (B.M.J.U.), VU University Medical Center, Amsterdam, the Netherlands; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK; The Osteoporosis Clinic (P.V.), Aarhus University Hospital, Aarhus, Denmark; National Institute of Public Health (J.B.), University of Southern Denmark, Copenhagen; and Department of Clinical Pharmacy and Toxicology (F.d.V.), Maastricht University Medical Centre, Maastricht, the Netherlands.
PharmD博士
这篇文章需要订阅查看全文。如果你有一个订阅你可以用下面的登录表单查看文章。这篇文章也可以购买。
寻求帮助,请联系:
河畔成员(800)879 - 1960或(612)928 - 6000(国际)
Non-AAN会员用户(800)638 - 3030或(301)223 - 2300选项3,选择1(国际)
报名
信息订阅神经病学和神经学:临床实践中可以找到首页在这里
购买
个人访问的文章可以通过这篇文章页面上加入购物车选项。获得1天(从您目前正在使用的计算机)是39.00美元。按次计费的内容仅供使用收款人和内容可能不会进一步分布式打印或电子手段。收款人可以查看、下载或打印文章为他/她的个人、学术研究和教学使用。分发副本(电子或其他方式)的文章是不允许的。
信:快速的网络通信
你可能也会感兴趣
广告
相关文章
-
没有找到相关文章。
提醒我
推荐的文章
- 文章
多发性硬化患者骨折的风险以人群为基础的队列研究
M.T. Bazelier陈宗柏。当前科技成果鉴定范,B.M.J. Uitdehaag et al。
首页神经学,2012年5月16日 - 文章
使用抗癫痫药物和骨折的风险病例对照研究在癫痫患者
p c . Souverein d·j·韦伯j·g·威尔等。
首页神经学,08年5月,2006 - 临床和伦理挑战
骨质疏松症的神经学家Micol s Rothman英镑g .西方,迈克尔·t·麦克德莫特et al。
首页神经学:临床实践,2013年11月13日 - 社论
在多发性硬化症跌倒和骨折的风险海伦Tremlett,罗宾·卢卡斯et al。
首页神经学,2012年5月16日